Global Epidemiology and Risk Factors of HCC

Man-Fung Yuen (The Univ. of Hong Kong, Hong Kong)

HCC in Patients with NASH: Epidemiology, Risk Factors, and Surveillance

Ryosuke Tateishi (The Univ. of Tokyo, Tokyo)

Cost-Effectiveness of HCC Surveillance

Amit Singal (UT Southwestern Medical Center, Texas)

Outcome of National HCC Surveillance Program in Korea

Do Young Kim (Yonsei Univ., Seoul)

Radiotherapy of HCC: From Palliation to Cure

Jinsil Seong (Yonsei Univ., Seoul)

The Updates and Future of Liver Surgery in the New Eras of TKI Drug and Immunotherapy

Kiyoshi Hasegawa (The Univ. of Tokyo, Tokyo)

Surgical Management of HCC beyond the BCLC Guidelines

Tan To Cheung (The Univ. of Hong Kong, Hong Kong)

Minimally Invasive LDLT

Kyung-Suk Suh (Seoul National Univ., Seoul)

Precision Therapies in Liver Transplantation for Cancer Recurrence: Biology, Genomics and Immunology

Jian Zhou (Fudan Univ., Shanghai)

Chemoembolization: Changing Role in the Real World with Introduction of New Systemic Agents

Toshihiro Tanaka (Nara Medical Univ., Kashihara)

Future Role of Locoregional Therapy for HCC: Hepatologist’s Perspective

Joong-Won Park (National Cancer Center Korea, Goyang)

Local Radiotherapy as an Immunomodulator in HCC

Jason Chia-Hsien Cheng (National Taiwan Univ., Taipei)

Abscopal Effects of Radiotherapy in HCC

Hee Chul Park (Sungkyunkwan Univ., Seoul)

Role of Systemic Therapy in Early HCC Patients: Hepatologist Perspectives

Masatoshi Kudo (Kindai Univ., Osaka)

Role of Systemic Therapy in Early HCC Patients: Interventional Radiologist Perspectives

Jin Wook Chung (Seoul National Univ., Seoul)

Tumor Immune Microenvironment in HCC

Tim Greten (National Cancer Institute, Maryland)

APPLE General Meeting

Satellite Symposium-Roche

Risk Models for HCC Development under Antiviral Therapy in CHB

Jia-Horng Kao (National Taiwan Univ., Taipei)

Comparison of Tenofovir versus Entecavir on Reducing Incidence of HCC in CHB

Jidong Jia (Beijing Friendship Hospital, Beijing)

Antiviral Therapy in Immune-Tolerant CHB: Pros

Young-Suk Lim (Univ. of Ulsan, Seoul)

Antiviral Therapy in Immune Tolerant CHB Cons

Grace L. H. Wong (The Chinese Univ. of Hong Kong, Hong Kong)

Intratumoural Immune Heterogeneity as a Hallmark of Tumor Evolution in HCC

Valerie Chew (Duke-NUS Medical School, Singapore)

Pathological and Molecular Features Related to Cancer Stemness of HCC

Young Nyun Park (Yonsei Univ., Seoul)

HCC Genomics Using Single Cell Analysis

Irene Ng (The Univ. of Hong Kong, Hong Kong)

LI-RADS: Pitfalls and Problems or How to Use LR-M and Ancillary Features

Victoria Chernyak (Albert Einstein College of Medicine, New York)

MR Imaging Phenotype of HCC and Histologic Correlation

Jin-Young Choi (Yonsei Univ., Seoul)

Application of Radiomics for Primary Liver Cancer

Seong Soo Lee (Univ. of Ulsan, Seoul)

AI for the Prediction, Diagnosis, and Treatment of HCC

Jeong-Hoon Lee (Seoul National Univ., Seoul)